Pembrolizumab Plus Chemotherapy For Previously Untreated, Her2-Negative Unresectable Or Metastatic Advanced Gastric Or Gastroesophageal Junction (G/Gej) Adenocarcinoma: Keynote-859.

Josep Tabernero,Yung-Jue Bang,Eric Van Cutsem,Charles S. Fuchs,Yelena Y. Janjigian,Pooja Bhagia,Kan Li,David E. Adelberg,Shu Kui Qin

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 2|浏览20

暂无评分

摘要

TPS263Background: For patients with unresectable, locally advanced recurrent or metastatic G/GEJ cancer, the standard of care includes a fluoropyrimidine plus a platinum-based agent as first-line t...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要